
Reportlinker Adds Animal Biotechnology - Technologies, Markets and Companies
NEW YORK, Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Animal Biotechnology - Technologies, Markets and Companies
http://www.reportlinker.com/p0203534/Animal-Biotechnology---Technologies-Markets-and-Companies.html
Summary
This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.
Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals. There is discussion of in vitro meat production by culture
Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans. RNA interference technology is now being applied for research in veterinary medicine
Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.
Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.
Approximately 102 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 105 collaborations in this area are shown.
Share of biotechnology-based products and services in 2009 is analyzed and the market is projected to 2019.
The text is supplemented with 34 tables and 5 figures. Selected 250 references from the literature are appended.
TABLE OF CONTENTS
0. Executive Summary 13
1. Introduction to Animal Biotechnology 15
Introduction 15
Historical evolution of animal biotechnology 15
Basics of biotechnology 16
DNA 16
RNA 16
Genes 17
Single nucleotide polymorphisms 17
Copy number variations in the genome 17
DNA sequences 18
Gene expression 18
Gene regulation 19
Proteins 19
Functions of proteins 19
Recombinant proteins 20
Monoclonal antibodies 21
Animal genetics 21
Molecular genetics 21
Twinning in cattle 22
Pig genetics 22
Genetic studies in dogs 22
Animal genomics 22
The mouse genome 22
The dog genome 23
Sequencing of the dog genome 23
Comparison of genomes of healthy and diseased dogs 25
Analysis of DNA copy number variation 25
The cat genome 26
Marsupial genomes 26
Genomes of non-human primates 26
Chimpanzee genome 26
Genome of the rhesus macaque 27
Livestock genomics 27
Bovine genome 28
Bovine SNP map 29
Pig genome 29
Horse genome 30
Sheep genome 31
Chicken genome 31
Turkey genome 32
Salmon genome 33
Priority genome list of the National Human Genome Research Institute 33
Applications of animal genomics 34
Genomics of disease resistance 34
Statistical genomics to improve breeding 35
Chicken breeding based on genomics 35
Animal proteomics 35
Applications of proteomics in animals 36
Caseins in goat milk 36
Lactic acid bacteria 36
Applications of proteomics in animal healthcare 37
Bioinformatics 37
Application of nanobiotechnology for animal health 38
Biomarkers and animal health 38
Recombinant protein manufacture 39
Animal biotechnology in relation to other technologies 39
2. Application of Biotechnology in Animals 41
Introduction 41
Genetic engineering 41
Livestock improvement by genetic engineering 41
Disease control by genetic engineering 41
Limitations and precautions for genetic engineering 42
Transgenic animal technology 42
Cloning animals 43
Nuclear transfer technology 43
Nuclear bisection for cloning 45
Zona-free cloning method 45
Abnormalities in cloned animals 46
Cloning from embryonic cells 47
Cloning of rabbits 47
Cloning the rat 48
Cloning the horse 48
Cloning the cow 48
Cloning the dog 49
Cloning in primates 49
Retrovector-mediated production of transgenic animals 49
Episomal vector-mediated gene delivery 50
Sperm-mediated gene transfer 50
Lentiviral transduction of male germ-line stem cells 51
Lentiviral transgenesis 52
Transgenic pharmaceuticals 52
Proteins from the milk of transgenic animals 52
Advantages of milk as source of transgenic proteins 53
Therapeutic proteins from rabbit milk 54
Recombinant human antibodies from cows 55
Therapeutic proteins from goat milk 55
Chicken transgenesis for the production of biopharmaceuticals 56
Concluding remarks about production of recombinant proteins in animals 56
Companies involved in production of transgenic pharmaceuticals 56
Transgenic food products 57
Milking genetically modified cows 57
Transgenic fish 57
Cloned animals as sources of milk and meat 58
Animal feeds from transgenic plants 58
Transgenic modification of plants to increase nutritional value of animal feeds 59
Transgenic disease models 59
Technologies to create transgenic disease models 59
Gene manipulation techniques 59
Embryonic stem cells for gene targeting 60
Homologous recombination 60
Animal models of human diseases 61
Transgenic models for studying human drug metabolism and toxicity 61
The Human Genome Project and the role of transgenics 62
Genomic and proteomic analyses of transgenic animal models 62
Concern about health and welfare of transgenic animals 63
Safety of transgenic technology 63
Concluding remarks about use of transgenic animals 64
RNA interference technology 64
RNAi versus antisense 64
Applications of RNAi in animal biotechnology 64
Xenotransplantation 65
Pigs for xenotransplantation 65
Genetically engineered pigs for transplants 66
Risks of xenotransplantation 66
World Health Organization and xenotransplantation 67
Ethical aspects of animal biotechnology 67
3. A Biotechnology Perspective of Animals Diseases 69
Introduction 69
Infections in animals 69
Viral infections 70
Avian influenza 70
Animal surveillance of influenza 72
Animal biotechnology implications of H1N1 influenza 73
Animal corona viruses and human SARS 73
Avian coronavirus 74
Bluetongue virus 75
Canine parvovirus 75
Classical swine fever 75
Developing new treatments against FMD 75
Equine infectious anemia 76
Foot-and-mouth disease 77
Porcine reproductive and respiratory syndrome virus 78
Rabies 79
Rinderpest 79
Bacterial infections 79
Bovine tuberculosis 79
Mycoplasmal pneumonia 80
Protozoal infections 80
Coccidiosis 80
Neosporosis 81
Toxoplasmosis 81
Trypanosomiasis 81
Nematodes 82
Infections that cross the species barrier 82
Complications of bacterial infections and antibiotic use in animals 82
Transmissible spongiform encephalopathies (TSEs) 83
Inter-species transfer of prions 83
Scrapie 83
Bovine spongiform encephalopathy 84
Epidemiology of BSE 84
Biomarkers in the urine of BSE infected cattle 85
Human health implications of BSE 85
Breeding animals protected against BSE 86
TSE research 86
Prion gene haplotyping 86
Pharmacological approaches to TSE research. 86
Molecular diagnostic approach to TSE research 87
RNAi for knockdown of the bovine prion gene 87
Chronic wasting disease 88
Chronic wasting disease in wildlife 88
Chronic wasting disease of the cattle in Sudan 89
Chronic wasting in dairy cows in the Netherlands 89
Genetic disorders in farm animals 89
Genetic predisposition to acquired diseases in animals 90
Diseases of pet animals 90
Canine anemia 90
Cardiovascular disease 90
Heart failure 91
Cardiac complications of canine babesiosis 91
Diabetes 91
Role of biotechnology in management of diabetes 92
Arthritis 92
Cancer in cats and dogs 93
Cancer clinical trials in dogs 93
Canine Comparative Oncology Genomics Consortium 94
Preventive veterinary medicine 94
Prevention of introduction of foreign animal diseases 94
Producing transgenic cattle resistant to BSE 95
Zoonotic diseases 95
Collaborative management of animal and human health 96
Vaccines for zoonotic viral diseases 96
4. Molecular Diagnostics in Animals 97
Introduction 97
Nucleic acid technologies 97
The polymerase chain reaction 97
Basic Principles of PCR 97
Target selection 98
Detection of amplified DNA 98
Real-time PCR systems 98
LightCycler PCR system 99
Molecular beacons 99
Applications of PCR in veterinary medicine 99
Fluorescent in situ hybridization 100
Immunodiagnostics 102
Enzyme-linked immunoassays 102
Bovine Gamma Interferon Test 102
Antigen diagnosis of trichinosis 103
Parachek™ for the diagnosis of Johne's disease 103
Antibodies for differentiation between vaccinated and infected animals 104
Biochip/microarray technology 104
Applications of microarrays in animal biotechnology 105
Cattlearray3800 for functional genomics 105
eSensor™ electrochemical biochip 106
FR 48 microfluidic biochip 106
Biosensors 106
Immunosensors 107
Biosensor for ovulation prediction in dairy cows 107
Flow cytometry for animal diagnostics 108
Molecular imaging in animals 108
Veterinary cytogenetics 109
Applications of molecular diagnostics in animals 109
Canine DNA testing 110
Diagnostic aids to selective breeding 110
Selection of desirable traits 110
Using genetic markers for improved milk production in dairy cattle 111
Application of bovine genomics for improving milk yield 111
Recognition of hereditary syndromes 112
Genetic markers in animals 112
SNP genotyping in animals 112
SNP genotyping for selective breeding of chicken 112
Animal identity and parentage analysis 113
Animal species identification in food 113
Diagnosis of infections 114
Bacterial infections 114
Diagnosis of viral infections 114
Molecular diagnosis of avian influenza 116
Diagnosis of parasitic infections 117
Detection of natural or bioterror threats to livestock 118
Molecular diagnosis of prion diseases 118
Bovine spongiform encephalopathy 118
Testing for BSE in living animals 120
Prions in urine 120
Diagnosis of chronic wasting disease in wildlife 121
Developing new tests for prion diseases 121
Differentiation among various types of TSEs 121
Protein cyclic amplification 122
Antibody tests for prion diseases 122
Scrapie genotyping 122
A real-time ultrasonic method for prion protein detection 123
Companies involved in developing molecular diagnostics for TSEs 123
Diagnosis of genetic disorders 124
Genetic screening of companion animals 124
Genes associated with exercise-induced collapse 124
Preimplantation genetic diagnosis 124
Diagnosis of cancer in animals 125
Diagnosis of food-borne pathogens 125
Introduction 125
Molecular diagnostic methods used in food-borne infections 126
Limitations of use of molecular probes in food analysis 126
Companies with technologies for food pathogen detection 127
Biotechnology-based novel diagnostics for aquatic animals 128
Detection of chemicals in foods of animal origin 128
Companies developing molecular diagnostics for animals 129
5. Biotechnology-based Veterinary Medicine 131
Introduction 131
Biotechnology versus pharmaceutical products 131
Role of biotechnology in drug discovery and development 132
Cost of veterinary vs. human drug discovery and development 132
Advantages and disadvantages of testing biotech products in animal models 133
Biotechnolgoy-based antiparasitic drugs 133
Non-antibiotic strategies for control of infections in animals 133
Probiotics 134
Potential role for probiotics in the human gut 134
Potential role for probiotics in animals 134
Probiotic bacteria for control of pathogens in cattle 134
Nonantibiotic drugs for infections in animals 135
Immunomodulation as an alternative to antibiotics in infections 136
Cathelicidins: effector molecules of mammalian innate immunity 136
Bacteriophage therapy for antibiotic resistance 136
Biotechnology for treating tendon injuries 137
Use of growth factors to facilitate tendon injuries 137
Productivity enhancers 137
Bovine somatotropin for increasing milk production in dairy cows 138
Increasing milk production in cows by feeding propionibacteria 139
Use of growth factors 139
Transgenic plant products for use in animals 139
Biotechnology-based vaccines 140
Modern vaccines without viral non-structural proteins 140
Plant-derived vaccines for use in animals 141
Nano-bead vaccine adjuvant 142
Genetically engineered vaccines 142
Application of nucleic acid vaccines in veterinary medicine 142
DNA vaccines 142
DNA vaccine for tuberculosis 144
DNA vaccines for West Nile encephalitis 144
Gene-based vaccine for Marek's disease 145
Genetic engineering of live rabies vaccines 146
Genetically engineered vaccines for equine encephalitis 146
Genetically engineered vaccines for Johne's disease 146
Vaccines against avian influenza 147
Vaccines against parasitic infections 148
Recombinant marker vaccines 148
Marker vaccines for foot-and-mouth disease 148
Marker vaccine for Newcastle disease 149
Vaccines for classical swine fever 149
Vaccines for tick control 150
Vaccination to protection swine from H1N1 influenza virus infection 150
Vaccination of cattle to prevent E. coli transmission to consumers in meat 150
Vaccines for bacterial equine respiratory infections 151
Using RNAi to develop vaccines for viral infections in prawns 151
Companies developing biotechnology-based vaccines 152
Biotechnology in treatment of parasitic infections 152
Biotechnology in the treatment of CNS injuries in pet animals 153
Paraplegia due to acute spinal cord injury in dogs 153
RNAi for suppression prions in livestock 153
Cell Therapy 154
Umbilical cord blood stem cells 154
Application of stem cells in veterinary medicine 154
Use of stem cells to repair tendon injuries in horses 154
Stem cells for spinal cord injury in dogs 155
Gene therapy 155
Gene therapy vectors 156
Gene therapy by mitochondrial transfer 156
In utero gene therapy 157
Applications of gene therapy in veterinary medicine 157
Gene therapy for mucopolysaccharidosis VII in dogs 157
Gene therapy to increase disease resistance 158
Gene therapy for infections 158
Gene therapy for hematological disorders 158
Gene therapy for cardiomyopathy in dogs 159
Gene therapy for endocrine disorders 159
Gene therapy for arthritis 160
Gene therapy for renal failure 160
Cancer gene therapy 160
Antiangiogeneic cancer gene therapy in dogs 161
Brain tumors in cats and dogs 161
Breast cancer in dogs 162
Canine hemangiosarcoma 162
Canine melanoma 163
Canine soft tissue sarcoma 164
Melanoma in horses 164
6. Research in Animal Biotechnology 165
Introduction 165
Research institutes 165
Animal and Natural Resources Institute (USDA) 165
Center for Animal Biotechnology at University of Melbourne (Australia) 166
CSIRO Livestock Industries 167
Danish Veterinary Institute 168
Friedrich-Loeffler-Institute 168
Indian Veterinary Research Institute 169
Institute for Animal Health of UK 169
Kimron Veterinary Institute 170
Korean National Livestock Research Institute 170
National Agricultural & Veterinary Biotechnology Center of Ireland 171
Swiss Federal Institute of Technology 171
Veterinary Laboratories Agency of UK 172
Veterinary Medical University of Vienna 173
Ethical issues of research in animal biotechnology 173
Future prospects 173
Strategies for control of twining in cattle 174
Future developments of molecular diagnostics 174
Future of vaccine application in veterinary medicine 174
Promotion of innate immunity in animals 175
Identification of key parasite antigens for eliciting immune response 175
Virus-like particle vaccines for lasting immune response 175
Control of respiratory virus infections 176
Control and prevention of bioterrorism diseases in animals 176
Genetic control of disease resistance 176
Production of cattle lacking prion protein 177
Application of genetics and biotechnology to wildlife management 177
Future of animal genomics 178
Future prospects of in vitro meat production 178
7. Animal Biotechnology Markets 181
Introduction 181
Markets for biotechnology-based products for animal healthcare 182
Markets for biopharmaceuticals for animals 183
Markets for recombinant proteins for animal healthcare 183
Markets for vaccines for animals 184
Markets for animal diagnostics 184
Test for bovine spongiform encephalopathy 184
Animal biotechnology markets according to therapeutic areas 184
Markets for biotechnology-based animal products for humans 185
Transgenic proteins 186
Market for xenotransplantation 186
Strategies for promoting use of animal biotechnology 187
Financial losses from death and disease in animals 187
Losses in farm animals 187
Losses in poultry 187
Losses in equine industry 187
The emerging role of pet owners 187
Improvement in cattle through application of biotechnology 188
Economic aspects of genomic evaluation of dairy cattle 188
Pig market 188
Cattle Market 189
Poultry market 189
Milk from genetically modified cows 189
Transgenic fish 190
Role of biotechnology in livestock performace enhancer market 190
Gene transfer technologies 190
In vitro meat production and animal biotechnology markets 190
Cost-benefit aspects of transgenic proteins 190
Lower costs of transgenic production 190
Lower costs of treatment 191
Unmet needs in animal biotechnology 191
Future opportunities for biotechnology in animal healthcare 192
Farm animals 192
Companion animals 193
8. Regulatory issues 195
Introduction 195
Regulatory agencies for veterinary biotechnology in the US 195
FDA regulatory issues in agricultural biotechnology 196
FDA guidlines on use of antibiotics in food-producing animals 197
Food safety evaluation of transgenic animals 198
Food from cloned animals 198
FDA investigation of drug transfer into eggs 200
Animal feed safety 200
Medicated feeds 201
Regulatory issues for production of transgenic proteins 201
Risks of animal biotechnology 202
FDA regulation of bovine products 202
Worldwide biotechnology regulatory and trade issues 203
9. Companies Involved in Animal Biotechnology 205
Introduction 205
Biotechnology at top veterinary pharmaceutical companies 205
Profiles of selected companies 205
Collaborations 318
10. References 323
Tables
Table 1 1: Landmarks in the evolution of animal biotechnology in the 20th century 15
Table 1 2: Expression systems for production of recombinant proteins 20
Table 1 3: Applications of genomics in livestock industry and veterinary medicine 34
Table 1 4: Applications of proteomics in livestock industry and veterinary medicine 36
Table 1 5: Selected animal genomics and proteomics databases (DB) 37
Table 2 1: Recombinant proteins obtained from milk of transgenic animals 54
Table 2 2: Companies involved in the production of transgenic pharmaceuticals 57
Table 2 3: A comparison of gene knockout and transgenic techniques 60
Table 2 4: Examples of transgenic mouse models of non-neoplastic human diseases 61
Table 3 1: Diseases of dairy cattle 69
Table 3 2: Causes of chronic wasting disease in animals 88
Table 4 1: Potential applications of microarrays in animal biotechnology 105
Table 4 2: Biosensor technologies with potential applications in molecular diagnostics 107
Table 4 3: Applications of molecular diagnostics in animals 109
Table 4 4: Viruses that can be detected by molecular diagnostics 114
Table 4 5: Testing for harmful prions in brain tissue from dead cattle 119
Table 4 6: Companies involved in developing molecular diagnostics for TSEs 123
Table 4 7: Pathogenic bacteria in food and targets for molecular diagnostic probes 126
Table 4 8: Companies involved in molecular diagnostics for food-borne infections 127
Table 4 9: Companies developing molecular diagnostics for veterinary medicine 129
Table 5 1: Veterinary biotechnology products 131
Table 5 2: Pharmaceutical versus biotechnology products 132
Table 5 3: Nonantibiotic strategies for control of infections 133
Table 5 4: Experimental DNA vaccines tested in animals 143
Table 5 5: Companies developing biotechnology-based vaccines for animals 152
Table 6 1: Areas for future research applications of animal biotechnologies 174
Table 7 1: Worldwide markets for biotechnology-based products for farm animals: 2009-2019 182
Table 7 2: Worldwide markets for biotechnology-based products for pet animals: 2009-2019 182
Table 7 3: Biotechnology-based markets for animal healthcare according to regions: 2009-2019. 183
Table 7 4: Biotechnology markets for farm animals according to therapeutic areas: 2009-2019 185
Table 7 5: Biotechnology markets for pet animals in therapeutic areas: 2009-2019 185
Table 7 6: Worldwide markets for biotechnology-based animal products for humans: 2009-2019 186
Table 9 1: Ranking of top 5 veterinary companies with biotechnology products 205
Table 9 2: Selected collaborations of companies in animal biotechnology 318
Figures
Figure 1 1: Relation of animal biotechnology to other technologies and human health 39
Figure 2 1: Nuclear transfer technology 44
Figure 2 2: Generation of transgenic animals by linker based sperm-mediated gene transfer 51
Figure 2 3: Production of therapeutic proteins in the milk of transgenic animals. 53
Figure 7 1: Unmet needs in animal biotechnology 192
To order this report:
Biotechnology Industry: Animal Biotechnology - Technologies, Markets and Companies
Check our Company Profile, SWOT and Revenue Analysis!
Contact |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article